Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
Status:
Completed
Trial end date:
2018-10-20
Target enrollment:
Participant gender:
Summary
The purpose of this study was to demonstrate the efficacy and safety of omalizumab compared
with placebo, on top of SoC (anti-histamine and nasal corticosteroid) in adult and adolescent
patients with severe Japanese cedar pollinosis, whose symptoms were inadequately controlled
despite the current recommended therapies (nasal corticosteroids plus one or more medications
out of anti-histamine, leukotriene receptor antagonist, or prostaglandin D2/thromboxane A2
receptor antagonist) in the previous 2 Japanese cedar pollen seasons.